|
ALDH9A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.88178419700125E-16 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.99840144432528E-15 |
| Normal-vs-Stage2 |
2.380300E-03 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.62636570877339E-12 |
| Stage1-vs-Stage2 |
7.636300E-04 |
| Stage1-vs-Stage3 |
1.535390E-01 |
| Stage1-vs-Stage4 |
5.902400E-02 |
| Stage2-vs-Stage3 |
5.037000E-04 |
| Stage2-vs-Stage4 |
1.551120E-04 |
| Stage3-vs-Stage4 |
4.334600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
1.74052999999397E-05 |
| Normal-vs-Asian |
1.64834812466097E-12 |
| Caucasian-vs-AfricanAmerican |
1.526390E-01 |
| Caucasian-vs-Asian |
5.058200E-01 |
| AfricanAmerican-vs-Asian |
8.920300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.17350573702879E-13 |
| Normal-vs-Female |
1.62458935193399E-12 |
| Male-vs-Female |
9.130800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
8.88178419700125E-15 |
| Normal-vs-Age(61-80Yrs) |
1.2640999358382E-10 |
| Normal-vs-Age(81-100Yrs) |
1.231590E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.988400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.078640E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.204400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.151000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.703400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.765800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.54999999999661E-05 |
| Classical-VS-Follicular |
4.10880218737475E-11 |
| Classical-VS-Other |
7.483400E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
1.62458935193399E-12 |
| Tall-VS-Other |
2.766800E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.364060E-02 |
| Follicular-VS-Normal |
5.799500E-03 |
| Other-VS-Normal |
1.76681999999317E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.04851715987797E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
5.31640000023259E-07 |
|
|
